Consensus Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Market Closed - Nyse Other stock markets 01:30:02 15/07/2025 am IST			5-day change	1st Jan Change
120.69 ^USD	+2.17%		-0.43%	+8.22%

15/07	Morgan Stanley Adjusts Globe Life Price Target to $127 From $125	MT
10/07	Wells Fargo Raises Price Target on Globe Life to $144 From $139, Maintains Overweight Rating	MT

Evolution of the Average Target: Globe Life Inc.

Evolution of the Target Price: Globe Life Inc.

Changes in Analyst Recommendations: Globe Life Inc.

886054a7f68e6a7.DqXtwJfbUo9ZXPDn1Zs3Di52_Lka5UHZGMOMfoM0ees.Wsayk_uEANphap2fjPxgdnERy_5RtjC_IY_BScVxCZ9Rl4-E35hr2js1lw~d4f24fd131a04b3ec22b16e3acc50cfb

Analysts' recommendations: Globe Life Inc.

Morgan Stanley Adjusts Globe Life Price Target to $127 From $125	15/07	MT
Wells Fargo Raises Price Target on Globe Life to $144 From $139, Maintains Overweight Rating	10/07	MT
JPMorgan Adjusts Price Target on Globe Life to $160 From $145, Maintains Overweight Rating	08/07	MT
Jefferies Adjusts Price Target on Globe Life to $130 From $124	04/06	MT
Autonomous Research Adjusts Globe Life Price Target to $149 From $150	27/05	MT
BMO Capital Adjusts Price Target on Globe Life to $118 From $111, Maintains Market Perform Rating	20/05	MT
Morgan Stanley Adjusts Price Target on Globe Life to $125 From $117, Maintains Equalweight Rating	19/05	MT
Evercore ISI Adjusts Globe Life Price Target to $141 From $143, Maintains Outperform Rating	13/05	MT
Wells Fargo Adjusts Price Target on Globe Life to $139 From $140, Maintains Overweight Rating	06/05	MT
Piper Sandler Adjusts Price Target on Globe Life to $147 From $152	02/05	MT
Wells Fargo Adjusts Price Target on Globe Life to $140 From $141, Keeps Overweight Rating	10/04	MT
BMO Capital Adjusts Globe Life Price Target to $111 From $130, Maintains Market Perform Rating	09/04	MT
Morgan Stanley Adjusts Globe Life Price Target to $117 From $126, Maintains Equalweight Rating	09/04	MT
Piper Sandler Adjusts Price Target on Globe Life to $152 From $140, Maintains Overweight Rating	02/04	MT
JPMorgan Adjusts Price Target on Globe Life to $145 From $136, Maintains Overweight Rating	02/04	MT
Morgan Stanley Adjusts Price Target on Globe Life to $126 From $125, Maintains Equalweight Rating	28/02	MT
Autonomous Adjusts Price Target on Globe Life to $150 From $134	27/02	MT
Wells Fargo Adjusts Price Target on Globe Life to $141 From $126, Keeps Overweight Rating	19/02	MT
TD Cowen Adjusts Globe Life Price Target to $168 From $165	19/02	MT
Jefferies Adjusts Price Target on Globe Life to $115 From $110, Maintains Hold Rating	18/02	MT
BMO Capital Adjusts Globe Life Price Target to $130 From $114, Keeps Market Perform Rating	12/02	MT
Keefe, Bruyette & Woods Adjusts Price Target on Globe Life to $145 From $137	11/02	MT
Morgan Stanley Adjusts Price Target on Globe Life to $125 From $123, Maintains Equalweight Rating	10/02	MT
Truist Adjusts Price Target on Globe Life to $120 From $105	07/02	MT
Truist Securities Adjusts Globe Life Price Target to $120 From $105, Maintains Hold Rating	07/02	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	GLOBE LIFE INC.					+21.3%
	CHINA LIFE INSURANCE COMPANY LIMITED					-5.74%
	AIA GROUP LIMITED					+34.78%
	LIFE INSURANCE CORPORATION OF INDIA					+17.64%
	FUBON FINANCIAL HOLDING CO., LTD.					+4.05%
	JAPAN POST HOLDINGS CO., LTD.					+23.42%
	HDFC LIFE INSURANCE COMPANY LIMITED					+10.6%
	NN GROUP N.V.					+4.96%
	T&D HOLDINGS, INC.					+16.82%
	Average					+14.20%
	Weighted average by Cap.					+12.19%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

120.69USD

Average target price

146.40USD

Spread / Average Target

+21.30%

High Price Target

188.00USD

Spread / Highest target

+55.77%

Low Price Target

114.00USD

Spread / Lowest Target

-5.54%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
Wells Fargo Securities
JPMorgan Chase
Jefferies & Co.
Autonomous Research
BMO Capital
Evercore ISI
Piper Sandler
TD Cowen
Keefe Bruyette & Woods
Truist Securities
Raymond James
Keefe, Bruyette & Woods
Credit Suisse
Wolfe Research
J.P. Morgan Chase